Prostate Cancer Trials

Alliance A031201: Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer

• Men, ages 18 and older, diagnosed with progressive castration-resistant metastatic prostate cancer. For additional criteria, call our Clinical Trials office at (910) 715-2200.

• Atrial Fibrillation
• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Venous Thromboembolism - Cancer Related
• Lymphomas
• Kidney Cancer
• Lung Cancer
• Multiple Myeloma
• Ovarian Cancer
• Peritoneal Cancer
• Prostate Cancer
• Solid Tumors